These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 27273004)
1. Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects. Yamazaki T; Desai A; Goldwater R; Han D; Lasseter KC; Howieson C; Akhtar S; Kowalski D; Lademacher C; Rammelsberg D; Townsend R Clin Pharmacol Drug Dev; 2017 Jan; 6(1):66-75. PubMed ID: 27273004 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of Drug-Drug Interactions of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor, With Transporter Substrates Based on In Vitro and Clinical Studies. Shimizu R; Matsuzaki T; Oka R; Sonoyama T; Fukuhara T; Kuwata A; Matsuo Y; Kubota R J Clin Pharmacol; 2023 Aug; 63(8):918-927. PubMed ID: 37043676 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and Pharmacodynamic Evaluation of the Drug-Drug Interaction Between Isavuconazole and Warfarin in Healthy Subjects. Desai A; Yamazaki T; Dietz AJ; Kowalski D; Lademacher C; Pearlman H; Akhtar S; Townsend R Clin Pharmacol Drug Dev; 2017 Jan; 6(1):86-92. PubMed ID: 27278712 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults. Groll AH; Desai A; Han D; Howieson C; Kato K; Akhtar S; Kowalski D; Lademacher C; Lewis W; Pearlman H; Mandarino D; Yamazaki T; Townsend R Clin Pharmacol Drug Dev; 2017 Jan; 6(1):76-85. PubMed ID: 27273343 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic Evaluation of CYP3A4-Mediated Drug-Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults. Townsend R; Dietz A; Hale C; Akhtar S; Kowalski D; Lademacher C; Lasseter K; Pearlman H; Rammelsberg D; Schmitt-Hoffmann A; Yamazaki T; Desai A Clin Pharmacol Drug Dev; 2017 Jan; 6(1):44-53. PubMed ID: 27273461 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein. Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900 [TBL] [Abstract][Full Text] [Related]
7. The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail. Ebner T; Ishiguro N; Taub ME J Pharm Sci; 2015 Sep; 104(9):3220-8. PubMed ID: 25981193 [TBL] [Abstract][Full Text] [Related]
9. Impact of fedratinib on the pharmacokinetics of transporter probe substrates using a cocktail approach. Ogasawara K; Wood-Horrall RN; Thomas M; Thomas M; Liu L; Liu M; Xue Y; Surapaneni S; Carayannopoulos LN; Zhou S; Palmisano M; Krishna G Cancer Chemother Pharmacol; 2021 Dec; 88(6):941-952. PubMed ID: 34477937 [TBL] [Abstract][Full Text] [Related]
10. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide. Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502 [TBL] [Abstract][Full Text] [Related]
11. Identification of Transporters Involved in Beraprost Sodium Transport In Vitro. Oshida K; Shimamura M; Seya K; Ando A; Miyamoto Y Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):117-128. PubMed ID: 26961540 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic Interaction Between Isavuconazole and a Fixed-Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects. Yamazaki T; Desai A; Han D; Kato K; Kowalski D; Akhtar S; Lademacher C; Kovanda L; Townsend R Clin Pharmacol Drug Dev; 2017 Jan; 6(1):93-101. PubMed ID: 27273248 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy Subjects. Yamazaki T; Desai A; Goldwater R; Han D; Howieson C; Akhtar S; Kowalski D; Lademacher C; Pearlman H; Rammelsberg D; Townsend R Clin Pharmacol Drug Dev; 2017 Jan; 6(1):54-65. PubMed ID: 27273149 [TBL] [Abstract][Full Text] [Related]
14. Translation of In Vitro Transport Inhibition Studies to Clinical Drug-Drug Interactions for Glecaprevir and Pibrentasvir. Kosloski MP; Bow DAJ; Kikuchi R; Wang H; Kim EJ; Marsh K; Mensa F; Kort J; Liu W J Pharmacol Exp Ther; 2019 Aug; 370(2):278-287. PubMed ID: 31167814 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and Rosuvastatin. Stopfer P; Giessmann T; Hohl K; Sharma A; Ishiguro N; Taub ME; Zimdahl-Gelling H; Gansser D; Wein M; Ebner T; Müller F Clin Pharmacol Ther; 2016 Sep; 100(3):259-67. PubMed ID: 27256812 [TBL] [Abstract][Full Text] [Related]
16. The interactions of lenalidomide with human uptake and efflux transporters and UDP-glucuronosyltransferase 1A1: lack of potential for drug-drug interactions. Tong Z; Yerramilli U; Surapaneni S; Kumar G Cancer Chemother Pharmacol; 2014 Apr; 73(4):869-74. PubMed ID: 24627218 [TBL] [Abstract][Full Text] [Related]
17. Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects. Hausner H; Derving Karsbøl J; Holst AG; Jacobsen JB; Wagner FD; Golor G; Anderson TW Clin Pharmacokinet; 2017 Nov; 56(11):1391-1401. PubMed ID: 28349387 [TBL] [Abstract][Full Text] [Related]
18. Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics. Townsend RW; Akhtar S; Alcorn H; Berg JK; Kowalski DL; Mujais S; Desai AV Eur J Clin Pharmacol; 2017 Jun; 73(6):669-678. PubMed ID: 28271239 [TBL] [Abstract][Full Text] [Related]
19. Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes. Uchida Y; Goto R; Takeuchi H; Łuczak M; Usui T; Tachikawa M; Terasaki T Drug Metab Dispos; 2020 Feb; 48(2):135-145. PubMed ID: 31771948 [TBL] [Abstract][Full Text] [Related]
20. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure. Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]